Importance of the flow perfusion deficit in the response to captopril in experimental myocardial infarction. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Cardiovascular Pharmacology Année : 1992

Importance of the flow perfusion deficit in the response to captopril in experimental myocardial infarction.

Résumé

Previous results on the effects of angiotensin-converting enzyme (ACE) inhibition in myocardial ischemia are conflicting. To determine whether acute ACE inhibition may influence myocardial perfusion deficit during ischemia and reduce ischemia-reperfusion injury, anesthetized open-chest dogs underwent 2-h left anterior descending coronary artery (LAD) occlusion followed by 6-h reperfusion. After 1-h coronary occlusion, each dog was randomized to receive either captopril [5 mg/kg intravenous (i.v.) bolus and 0.25/kg/h infusion for 7 h] or saline. Whereas arterial pressure was reduced (p = 0.001), captopril did not influence myocardial perfusion deficit: Blood flow in the central ischemic zone represented 17.1 +/- 2.8% of the flow in the nonischemic zone versus 20.5 +/- 3.8% before treatment (NS). The values of the control group were 17.8 +/- 2.5 and 16.7 +/- 2.4%, respectively. In addition, there was no difference in infarct size: 35.9 +/- 3.3% of the area at risk in captopril-treated dogs versus 40.0 +/- 3.6% in controls. Analysis of subgroups based on the level of the collateral flow indicated, however, that ACE inhibition had an adverse effect on infarct size in dogs with high collateral flow: 31.9 +/- 4.6% in captopril dogs versus 17.6 +/- 4.7 (p = 0.048). This effect was related to a decrease in collateral flow because animals exhibiting the highest increase in perfusion deficit presented the greatest increase in infarct size (r = -0.92, p = 0.003). Although in dogs with low collateral flow, ACE inhibition appeared to exert a slight beneficial effect on infarct size, we conclude that at least in this dog model, acute ACE inhibition could exacerbate myocardial injury.
Fichier non déposé

Dates et versions

hal-00395772 , version 1 (16-06-2009)

Identifiants

  • HAL Id : hal-00395772 , version 1
  • PUBMED : 1378109

Citer

M. de Lorgeril, M. Ovize, J. Delaye, S. Renaud. Importance of the flow perfusion deficit in the response to captopril in experimental myocardial infarction.. Journal of Cardiovascular Pharmacology, 1992, 19 (3), pp.324-9. ⟨hal-00395772⟩
1014 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More